Skip to content
MarketScale
‹ Back to IndustriesHealthcare

THREE PREDICTIONS FOR THE INTERNET OF MEDICAL THINGS

The Internet of Medical Things is revolutionizing healthcare, and Sunrise Labs is at the forefront of product development for medical devices and life science instrumentation. Technological achievements have long propelled the healthcare industry forward, with advancements in surgical robotics and electronic health records enhancing care for today’s patients. The current medical landscape is evolving as…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

The Internet of Medical Things is revolutionizing healthcare, and Sunrise Labs is at the forefront of product development for medical devices and life science instrumentation.

Technological achievements have long propelled the healthcare industry forward, with advancements in surgical robotics and electronic health records enhancing care for today’s patients. The current medical landscape is evolving as a result of the Internet of Things (IoT) which is helping to improve the patient experience, streamline operations, reduce human errors, and decrease costs. In healthcare, IoT devices commonly include wireless technologies that clinicians leverage to collect and analyze actionable patient data, then use this data to create better and more specialized treatment plans. IoT devices hold great promise for the future of medicine. Here are three predictions for the Internet of Medical Things.

1.) A NETWORK OF INTEGRATED DEVICES:

Current IoT devices work in a self-contained, independent fashion, but the trend is toward an entire network of connections. The network will integrate a catalog of devices including sensors, wearables, mobile apps, smart pills, and measurement tools like digital scales and thermometer, all gathering and transmitting data into a central system for deeper analysis. With access to a plethora of real-time data that can be connected to electronic health records, clinicians will be able to form proactive strategies to improve patient care.

2.) FASTER, MORE ACCURATE DIAGNOSES:

Smart, Internet-connected wearables will help physicians improve the speed and accuracy of diagnoses. Performing tests to deduce the source of an illness involves some trial-and-error and can prove time-intensive, which not all patients can afford. Wearable health monitoring devices can remotely and continuously feed large quantities of data to a hub for manual or automated analysis. The analysis and insights will provide healthcare practitioners with a holistic picture of a patient’s health and may even help non-invasively diagnose an illness in real-time, which could mean the difference between life and death for some.

3.) BETTER ILLNESS PREVENTION AND TREATMENTS:

The best cure is prevention, and wearable health technologies will allow clinicians to help patients develop personalized illness prevention strategies to improve their overall health. When treatment is necessary, expect healthcare providers to increasingly recommend smart pills, smart inhalers, smart blood glucose monitors, and other smart ‘connected’ medical devices that can lead to better adherence rates when compared to their stand alone counterparts.

The Internet of Medical Things is revolutionizing healthcare, and Sunrise Labs is at the forefront of product development for medical devices and life science instrumentation. Our approach for developing connected devices includes architecting a solution with defined requirements, cloud connectivity and database creation, app development, and addressing cybersecurity risk through a comprehensive risk assessment.

Click here to learn more about our expertise in this space.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Leading with Purpose: Dr. David Foster on Faith, Healthcare Leadership, and Physician Collaboration

Dr. David Foster discusses the importance of faith in healthcare leadership and the role of physician collaboration. The conversation emphasizes how values-driven leadership can positively impact patient care. The dialogue also explores the significance of integrating personal beliefs in professional settings.

  • 01Values-driven leadership can significantly enhance patient care.
  • 02Integrating personal beliefs in professional settings can benefit healthcare leadership.
  • 03Collaboration among physicians is crucial for effective healthcare leadership.

Aug 4, 2026

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health venture funding reached $7.4B in the first half of 2026, with significant investments in AI agent platforms and chronic care tools. Mega-deals of over $100 million were a key driver of the funding surge.

  • 01Digital health VC funding hit $7.4 billion in the first half of 2026.
  • 02Mega-deals in AI agent platforms and chronic care tools exceeded $100 million.
  • 03AI, chronic care, and workforce tools dominate digital health investments.

Aug 4, 2026

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512